Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
EMD Serono
National Cancer Institute (NCI)
Mayo Clinic
Genentech, Inc.
ImmunityBio, Inc.
Hoffmann-La Roche
Inhibrx Biosciences, Inc
Exelixis
OncoC4, Inc.
Klus Pharma Inc.
SOLTI Breast Cancer Research Group
Checkpoint Therapeutics, Inc.
Cybrexa Therapeutics
Carisma Therapeutics Inc
Salubris Biotherapeutics Inc
RemeGen Co., Ltd.